81 related articles for article (PubMed ID: 27097566)
1. Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.
Zaleska J; Skorka K; Zajac M; Karczmarczyk A; Karp M; Tomczak W; Hus M; Wlasiuk P; Giannopoulos K
Br J Haematol; 2016 Aug; 174(4):582-90. PubMed ID: 27097566
[TBL] [Abstract][Full Text] [Related]
2. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
[TBL] [Abstract][Full Text] [Related]
3. A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.
Kronenberger K; Nössner E; Frankenberger B; Wahl U; Dreyling M; Hallek M; Mocikat R
J Immunother; 2008 Oct; 31(8):723-30. PubMed ID: 18779747
[TBL] [Abstract][Full Text] [Related]
4. Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells.
Karp M; Karczmarczyk A; Bojarska-Junak A; Purkot J; Chojnacki M; ZajĄc M; Korpysz M; Tomczak W; Hus M; Morawska M; Giannopoulos K
Anticancer Res; 2020 Nov; 40(11):6327-6335. PubMed ID: 33109570
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.
Chu CC; Catera R; Hatzi K; Yan XJ; Zhang L; Wang XB; Fales HM; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
Blood; 2008 Dec; 112(13):5122-9. PubMed ID: 18812466
[TBL] [Abstract][Full Text] [Related]
6. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
[TBL] [Abstract][Full Text] [Related]
7. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
Chu CC; Catera R; Zhang L; Didier S; Agagnina BM; Damle RN; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
Blood; 2010 May; 115(19):3907-15. PubMed ID: 20110421
[TBL] [Abstract][Full Text] [Related]
8. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
[TBL] [Abstract][Full Text] [Related]
9. Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
Kater AP; Remmerswaal EB; Nolte MA; Eldering E; van Oers MH; van Lier RA
Br J Haematol; 2004 Aug; 126(4):512-6. PubMed ID: 15287944
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
[TBL] [Abstract][Full Text] [Related]
11. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
12. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
13. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.
Jiménez de Oya N; De Giovanni M; Fioravanti J; Übelhart R; Di Lucia P; Fiocchi A; Iacovelli S; Efremov DG; Caligaris-Cappio F; Jumaa H; Ghia P; Guidotti LG; Iannacone M
EMBO Mol Med; 2017 Nov; 9(11):1482-1490. PubMed ID: 28899929
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
[TBL] [Abstract][Full Text] [Related]
17. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
[TBL] [Abstract][Full Text] [Related]
18. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells.
Zwick C; Fadle N; Regitz E; Kemele M; Stilgenbauer S; Bühler A; Pfreundschuh M; Preuss KD
Blood; 2013 Jun; 121(23):4708-17. PubMed ID: 23580660
[TBL] [Abstract][Full Text] [Related]
19. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
[TBL] [Abstract][Full Text] [Related]
20. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
